Fluence strikes deal to take Brazil's psychedelic therapy training scene to new heights

Psychedelic therapy training company Fluence partners with non-profit research organization Phaneros Institute based in Brazil.

Fluence will grant Phaneros access to its educational content through its online learning management system. An additional version of the training material translated into Brazilian Portuguese will also be available.

Phaneros, established in 2011 by Eduardo Schenberg, PhD, recently completed a pilot study related to MAPS' advanced research into MDMA-assisted therapy for PTSD.

The company is also working to gain approval for new studies to accelerate access to these therapies in the South American country.

See also: A Powerful Harm Reduction Service Model - Check Out Fireside's Psychedelic Peer Helpline

Fluence co-founder Elizabeth Nielson hailed the partnership and "the opportunity to help integrate psychedelic therapy into mainstream health care in Brazil."

Phaneros will receive "the tools it needs to effectively train therapists, resulting in the wider dissemination of the practice of research-based psychedelic therapy," it said. she declared.

Schenberg provided more details on a jointly launched ketamine therapy course in Brazil.

"We are already seeing our clinicians being challenged on how best to support patients, whether with off-label racemic ketamine or intranasal esketamine for depression, which is approved by the Brazilian regulator ANVISA," he said. said. "This course will be of interest to many clinicians and we hope will improve the safety and effectiveness of ketamine sessions in Brazil."

In addition to technical assistance, Fluence will help Phaneros run an MDMA-assisted therapy training program and offer consultation on research therapy manuals and study plans. He will also inform Phaneros training and research programs through guest lectures and webinars featuring researchers from the Brazilian institute.

Note: the Benzinga Cannabis Capital conference is back

Benzinga is all for psychedelics and cannabis. Our next 17th edition of the CCC will take place in Chicago, September 27-28. This is the place to do BUSINESS. So join us by getting your tickets today and secure your place at the EPICENTER of cannabis investing and branding!

Photo: Benzinga montage with photo by luchschenF and ANDREI ASKIRKA on Shutterstock.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.